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Amogh Joshi, DO, Emilee Kurtz, DO and Yehia Mishriki, MD 
Department of Medicine, Lehigh Valley Health Network, Allentown Pa.
INTRODUCTION 
Mycosis fungoides is the most common form of 
cutaneous T cell lymphoma. However, it is still 
incredibly rare, with an incidence of approximately  
6 cases per 1,000,000. Initial presentation often  
mimics more benign dermatologic conditions, 
presenting an early diagnostic challenge. 
METHODS
A 53 year old male, with no 
significant medical history, 
presented with a  progressively 
worsening body rash.  He had 
previously been empirically 
treated with emollients and 
topical  hydrocortisone, without 
improvement. Physical 
examination demonstrated 
multiple ovoid, elongated pink 
and  minimally raised plaques 
along the chest wall, abdomen and right  medial calf. 
RESULTS
Punch biopsy revealed an interstitial infiltrate composed of perivascular 
small lymphocytes within a prominent superficial dermal fibroplasia 
extending into the dermis. Lymphocytes were predominantly CD4-
positive with fewer CD8-positive T cells and absent eosinophils.  
CD5 staining was preserved but CD7 expression was decreased. 
These findings were consistent with mycosis fungoides. Initial 
treatment consisted of topical clobetasol and close follow-up.
CONCLUSION
Mycosis fungoides is a mature T cell lymphoma that initially presents 
with cutaneous manifestations. Progressively worsening disease can 
lead to lymphatic, hematologic and visceral involvement. A low 
threshold for biopsy should be maintained for any plaque-like rash 
that does not resolve after initial treatment. Patients, with a suspected 
early stage diagnosis require initiation on topical therapies and those 
with biopsies demonstrating lymphocytic atypia should be followed 
closely. Long term surveillance is crucial in staging disease and 
appropriately guiding continued therapeutic intervention. Clinicians 
must remain particularly cognizant of this cutaneous malignancy that 
masquerades as other benign dermatologic conditions.
Figure 1: Multiple ovoid, elongated 
pink plaques found on physical 
examination, consistent with 
Mycosis fungoides.
